Dart JKG, Papa V, Rama P, Knutsson KA, et al. The Orphan Drug for Acanthamoeba Keratitis (ODAK) trial: PHMB (polihexanide) 0.08% and placebo versus PHMB 0.02% and propamidine 0.1. Ophthalmology 2023 Oct 4:S0161-6420(23)00710.
PMID: 37802392